News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
11 18 2013 Landmark Drug Testing Index™ analysis from Quest Diagnostics coincides with passage of the Drug-Free Workplace Act 25 years ago todayDrug use among American workers declined dramatically over the past 25 years, although the rate of positive test results for certain drugs, including...
-
11 08 2013 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at...
-
10 17 2013 Adjusted diluted EPS from continuing operations of $1.02, vs. $1.15 in 2012 Reported diluted EPS from continuing operations of $2.66, vs. $0.98 in 2012...
-
10 15 2013 Also Releases Results from National Harris Survey Revealing Widespread Confusion about BRCA TestingQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of BRCAvantage™,...
-
10 15 2013 Seventy-two Percent (72 percent) of Adult Women in the U.S. Have Never Heard of BRCA Testing, yet 58 Percent Would Want to Know if They Carried High-Risk Gene MutationsAccording to the results of a recent Quest Diagnostics (NYSE: DGX) survey, seventy-two percent (72 percent) of American women age 18 and older have...